Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Gaumont goes Hollywood to win the film game

Article Abstract:

Gaumont SA is producing English-language French movies with Hollywood-size budgets, in an effort to penetrate the worldwide film market. In 1997, the company made money with its $90-million science-fiction film, "The Fifth Element," which grossed $270 million. Likewise, the movie, which starred Bruce Willis and directed by Luc Besson, was the most successful film export of France, with over 50 million tickets sold in foreign countries. Gaumont's next film is $55-million, English-language "Joan of Arc," a historical epic, which will be directed by Besson and starring Besson's wife, Milla Jovovich, who was also featured in "The Fifth Element."

Comment:

Is producing English-language French movies with Hollywood-size budgets, in an effort to penetrate the worldwide film market

Author: Barrett, Amy
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1998
Motion Picture and Video Industries, Motion Picture & TV Production, Article, Gaumont

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Coca-Cola may resume sales in Belgium

Article Abstract:

Coca-Cola Co. was given approval to restart soft drink sales in Belgium. However, the company struggled to show the French market that its drinks are safe for consumption. Coca-Cola's promises of improved quality-control measures reduced the chances for a reappearance of contaminants that caused the illness of hundreds of customers in Belgium and France. A prosecutor in France however, begin a probe into what caused the illnesses.

Comment:

Given approval to restart soft drink sales in Belgium

Author: Barrett, Amy, Hagerty, James R.
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
Product standards, safety, & recalls, Canned & Bottled Soft Drinks, Soft Drink Manufacturing, Belgium, Product defects and recalls, Soft drinks, Coca-Cola Co. (Atlanta, Georgia), Soft drink industry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Tabacalera and Seita to merge in deal valued at 3.08 billion euros

Article Abstract:

Tabacalera SA and Seita SA announced that they have reached an agreement on a merger valued at 3.08 billion euros. The two companies are the respective powers in the Spanish and French tobacco markets. Seita's chairman Jean-Dominique Comolli stated that both firms have similar core operations and corporate cultures. The newly-merged entity will be called Altadis. The deal will form the fourth-largest tobacco group in the world.

Author: Beck, Ernest, Barrett, Amy, Vitzhum, Carlta
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
Acquisitions & mergers, Organizational history, Spain, Tobacco Products, Tobacco Manufacturing, Management, Mergers, acquisitions and divestments, Tobacco industry, Tabacalera S.A., Seita S.A., Altadis

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: France, Abstract
Similar abstracts:
  • Abstracts: P&G promotes its image. Focus shifts away from Asia: P&G suspends sales of Tampax in some markets
  • Abstracts: Eyes on the prize. Time running out, again. The first minister's first day
  • Abstracts: Birth of a salesman. Graduate into reality. The bottom line
  • Abstracts: Tortuous process justified by the result. Goldman Sachs
  • Abstracts: Cable & Wireless says annual rate rose 91%. Cable & Wireless plans high-speed link. BT to take large stake in Korean firm
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.